Invention Grant
- Patent Title: Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders
-
Application No.: US18058109Application Date: 2022-11-22
-
Publication No.: US11939324B2Publication Date: 2024-03-26
- Inventor: Johan Gerard Griffioen , Katrien Princen , Tom Francois L. Van Dooren , Arnaud Didier Marie Marchand , Amuri Kilonda , Sara Allasia , Patrick Chaltin
- Applicant: reMYND N.V. , Katholieke Universiteit Leuven
- Applicant Address: BE Leuven
- Assignee: reMYND N.V.,Katholieke Universiteit Leuven
- Current Assignee: reMYND N.V.,Katholieke Universiteit Leuven
- Current Assignee Address: BE Leuven; BE Leuven
- Agency: Knobbe Martens, Olson & Bear LLP
- Priority: EP 170674 2017.05.11
- Main IPC: C07D413/12
- IPC: C07D413/12 ; A61P25/28
Abstract:
The present invention relates to a compound of formula (I) or a tautomer thereof, wherein R1, R2, R3, R4 and R5, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of epilepsy and/or neurodegenerative diseases.
Public/Granted literature
- US20230099111A1 COMPOUNDS FOR THE TREATMENT OF EPILEPSY, NEURODEGENERATIVE DISORDERS AND OTHER CNS DISORDERS Public/Granted day:2023-03-30
Information query
